A. Flynn

发表

Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.

D. Lane, U. Lindahl, L. Thunberg, 1984, The Biochemical journal.

Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4.

D. Lane, E. Thompson, G. Pejler, 1986, The Journal of biological chemistry.

ANTITHROMBIN III GLASGOW: A VARIANT WITH INCREASED HEPARIN AFFINITY AND REDUCED ABILITY TO INACTIVATE THROMBIN, ASSOCIATED WITH FAMILIAL THROMBOSIS

G. Lowe, H. Ireland, D. Lane, 1987, Thrombosis and Haemostasis.

Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosis

H. Morris, M. Greaves, M. Panico, 1989, British journal of haematology.

NEUTRALIZATION OF HEPARIN-LIKE SACCHARIDES BY COMPLEMENT S PROTEIN/VITRONECTIN

K. Preissner, D. Lane, J. Choay, 1987, Thrombosis and Haemostasis.

A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.

H. Ireland, D. Lane, E. Anastassiades, 1989, Clinical nephrology.

On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failure.

H. Ireland, D. Lane, E. Anastassiades, 1986, Haemostasis.

A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.

H. Ireland, D. Lane, E. Anastassiades, 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The Anticoagulant Effect of Heparinoid Org 10172 During Haemodialysis: An Objective Assessment

H. Ireland, D. Lane, H. Ireland, 1986, Thrombosis and Haemostasis.

Antithrombotic Properties of Dermatan Sulphate (MF 701) in Haemodialysis for Chronic Renal Failure

M. Boisclair, H. Ireland, D. Lane, 1992, Thrombosis and Haemostasis.

Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin

H. Ireland, D. Lane, E. Thompson, 1987, British journal of haematology.

Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms

P. Mather, Anthony Flynn, B. Chokkalingam Mani, 2010, Heart Failure Reviews.

Low Molecular Weight Heparin in Haemodialysis for Chronic Renal Failure: Dose Finding Study of CY222

H. Ireland, D. Lane, A. Pegrum, 1988, Thrombosis and Haemostasis.

Dose Finding Study of a Low Molecular Weight Heparin, Innohep, in Haemodialysis

H. Ireland, D. Lane, A. Flynn, 1991, Thrombosis and Haemostasis.

Heparin and Low Molecular Weight Heparin(oid)s as Anticoagulants in Hemodialysis for Chronic Renal Failure

H. Ireland, D. Lane, A. Flynn, 1989 .

Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.

H. Ireland, D. Lane, E. Anastassiades, 1986, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

HEMODIALYSIS WITH KABI 2165 - DOSAGE REQUIREMENTS FOR THE ELIMINATION OF EXTRACORPOREAL FIBRIN FORMATION

H. Ireland, D. Lane, E. Anastassiades, 1985 .